Company · CIK 0001093557 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq
DEXCOM INC · DXCM
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2017 SForm 4 → | Sep 13, 6:23 pm EDT | Andrew K BaloEVP, Reg. Strategy, Clinical | 3,244 | $72.27 | $234,441 | 96,813 | −3.24% | plan? |
| Sep 11, 2017 DForm 4 → | Sep 13, 6:22 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 7,531 | $71.81 | $540,827 | 65,049 | — | plan? |
| Sep 7, 2017 AForm 4 → | Sep 8, 7:47 pm EDT | Quentin S. BlackfordEVP, CFO, PFO & PAO | 62,358 | $0.001 | $62 | 63,756 | — | plan? |
| Aug 23, 2017 SForm 4 → | Aug 24, 7:31 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 3,987 | $75.26 | $300,045 | 108,087 | −3.56% | plan? |
| Aug 23, 2017 SForm 4 → | Aug 24, 7:31 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 1,635 | $75.26 | $123,053 | 23,785 | −6.43% | plan? |
| Aug 23, 2017 DForm 4 → | Aug 24, 7:31 pm EDT | Heather S AceSVP Human Resources | 2,617 | $75.33 | $197,145 | 46,766 | — | plan? |
| Aug 11, 2017 SForm 4 → | Aug 15, 5:52 pm EDT | Kevin R SayerPresident & CEO, Director | 6,000 | $69.77 | $418,637 | 320,680 | −1.84% | plan? |
| Aug 10, 2017 SForm 4 → | Aug 11, 5:54 pm EDT | Andrew K BaloEVP, Reg. Strategy, Clinical | 3,244 | $71.18 | $230,921 | 99,989 | −3.14% | plan? |
| Jul 24, 2017 SForm 4 → | Jul 25, 8:55 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 1,450 | $69.47 | $100,725 | 112,074 | −1.28% | plan? |
| Jul 12, 2017 SForm 4 → | Jul 12, 5:33 pm EDT | Kevin R SayerPresident & CEO, Director | 6,000 | $71.86 | $431,174 | 326,680 | −1.80% | plan? |
| Jul 10, 2017 SForm 4 → | Jul 12, 5:32 pm EDT | Andrew K BaloEVP, Reg. Strategy, Clinical | 3,200 | $71.55 | $228,972 | 103,233 | −3.01% | plan? |
| Jun 23, 2017 SForm 4 → | Jun 27, 6:56 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 3,187 | $78.22 | $249,273 | 25,420 | −11.1% | plan? |
| Jun 23, 2017 SForm 4 → | Jun 27, 6:55 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 1,450 | $78.19 | $113,378 | 113,524 | −1.26% | plan? |
| Jun 12, 2017 SForm 4 → | Jun 13, 5:27 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 3,200 | $69.06 | $220,989 | 106,433 | −2.92% | plan? |
| Jun 12, 2017 SForm 4 → | Jun 13, 5:26 pm EDT | Kevin R SayerPresident & CEO, Director | 6,000 | $69.07 | $414,411 | 332,680 | −1.77% | plan? |
| Jun 1, 2017 AForm 4 → | Jun 5, 8:50 pm EDT | Jay S SkylerDirector | 4,553 | $0.001 | $5 | 4,553 | — | plan? |
| Jun 1, 2017 AForm 4 → | Jun 5, 8:50 pm EDT | Barbara KahnDirector | 4,353 | $0.001 | $4 | 4,353 | — | plan? |
| Jun 1, 2017 AForm 4 → | Jun 5, 8:49 pm EDT | Nicholas AugustinosDirector | 4,353 | $0.001 | $4 | 31,015 | — | plan? |
| Jun 1, 2017 AForm 4 → | Jun 5, 8:48 pm EDT | Mark G FolettaDirector | 4,952 | $0.001 | $5 | 20,595 | — | plan? |
| Jun 1, 2017 AForm 4 → | Jun 5, 8:48 pm EDT | Richard Alexander CollinsDirector | 5,355 | $0.001 | $5 | 5,855 | — | plan? |
| Jun 1, 2017 AForm 4 → | Jun 5, 8:47 pm EDT | Steven R AltmanDirector | 4,353 | $0.001 | $4 | 4,353 | — | plan? |
| Jun 1, 2017 AForm 4 → | Jun 5, 8:47 pm EDT | Eric TopolDirector | 4,653 | $0.001 | $5 | 4,653 | — | plan? |
| Jun 1, 2017 DForm 4 → | Jun 5, 8:02 pm EDT | Donald AbbeyEVP Quality | 7,784 | $66.38 | $516,707 | 74,726 | — | plan? |
| May 24, 2017 MForm 4 → | May 26, 4:24 pm EDT | Terrance H GreggExecutive Chairman, Director | 30,000 | $6.85 | $205,500 | 484,559 | — | plan? |
| May 23, 2017 SForm 4 → | May 25, 7:16 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 1,450 | $68.24 | $98,949 | 114,974 | −1.25% | plan? |
| May 23, 2017 SForm 4 → | May 25, 7:15 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 3,182 | $68.29 | $217,290 | 28,607 | −10.0% | plan? |
| May 17, 2017 SForm 4 → | May 18, 5:46 pm EDT | Kevin R SayerPresident & CEO, Director | 8,649 | $68.39 | $591,525 | 338,680 | −2.49% | plan? |
| May 17, 2017 MForm 4 → | May 18, 5:46 pm EDT | Kevin R SayerPresident & CEO, Director | 3,649 | $8.79 | $32,075 | 347,329 | — | plan? |
| May 16, 2017 GForm 4 → | May 17, 7:36 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 1,000 | — | — | 116,424 | — | plan? |
| May 10, 2017 SForm 4 → | May 12, 6:19 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 3,200 | $71.93 | $230,176 | 109,633 | −2.84% | plan? |
| Apr 24, 2017 SForm 4 → | Apr 26, 7:04 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 1,450 | $75.89 | $110,041 | 117,424 | −1.22% | plan? |
| Apr 24, 2017 SForm 4 → | Apr 26, 7:04 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 3,182 | $75.78 | $241,131 | 6,369 | −33.3% | plan? |
| Apr 20, 2017 SForm 4 → | Apr 24, 6:13 pm EDT | Terrance H GreggExecutive Chairman, Director | 15,000 | $74.10 | $1,111,500 | 40,882 | −26.8% | plan? |
| Apr 17, 2017 SForm 4 → | Apr 19, 5:20 pm EDT | Kevin R SayerPresident & CEO, Director | 10,000 | $75.63 | $756,317 | 343,680 | −2.83% | plan? |
| Apr 17, 2017 MForm 4 → | Apr 19, 5:20 pm EDT | Kevin R SayerPresident & CEO, Director | 10,000 | $8.79 | $87,900 | 353,680 | — | plan? |
| Apr 10, 2017 SForm 4 → | Apr 12, 5:31 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 3,200 | $78.19 | $250,208 | 112,833 | −2.76% | plan? |
| Mar 23, 2017 SForm 4 → | Mar 24, 5:54 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 3,987 | $76.25 | $304,006 | 118,874 | −3.25% | plan? |
| Mar 23, 2017 SForm 4 → | Mar 24, 5:53 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 3,182 | $76.38 | $243,029 | 9,551 | −25.0% | plan? |
| Mar 22, 2017 SForm 4 → | Mar 24, 5:53 pm EDT | Jess RoperSVP, CFO | 2,000 | $75.97 | $151,937 | 8,452 | −19.1% | plan? |
| Mar 17, 2017 SForm 4 → | Mar 21, 6:03 pm EDT | Kevin R SayerPresident & CEO, Director | 10,000 | $77.82 | $778,158 | 343,680 | −2.83% | plan? |
| Mar 17, 2017 MForm 4 → | Mar 21, 6:03 pm EDT | Kevin R SayerPresident & CEO, Director | 10,000 | $8.79 | $87,900 | 353,680 | — | plan? |
| Mar 14, 2017 SForm 4 → | Mar 16, 6:04 pm EDT | Barbara KahnDirector | 3,000 | $77.36 | $232,080 | 21,304 | −12.3% | plan? |
| Mar 13, 2017 SForm 4 → | Mar 14, 7:59 pm EDT | Jorge A ValdesCTO | 14,400 | $77.74 | $1,119,514 | 10,442 | −58.0% | plan? |
| Mar 10, 2017 DMForm 4 → | Mar 15, 8:40 pm EDT | Jacob Steven LeachSVP, Research & Development | 17,461 | $47.52 | $829,707 | 93,131 | — | plan? late |
| Mar 10, 2017 DJForm 4 → | Mar 14, 7:59 pm EDT | Jorge A ValdesCTO | 80,914 | $78.10 | $6,319,052 | 24,842 | — | plan? |
| Mar 10, 2017 DForm 4 → | Mar 14, 7:58 pm EDT | Jess RoperSVP, CFO | 9,606 | $77.55 | $744,951 | 46,497 | — | plan? |
| Mar 10, 2017 DJForm 4 → | Mar 14, 7:58 pm EDT | Jeffrey MoySVP, Operations | 63,895 | $78.11 | $4,990,946 | 64,664 | — | plan? |
| Mar 10, 2017 DForm 4 → | Mar 14, 7:57 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 13,430 | $77.55 | $1,041,505 | 116,033 | — | plan? |
| Mar 10, 2017 SForm 4 → | Mar 14, 7:57 pm EDT | Andrew K BaloEVP, Clinical and Regulatory | 3,200 | $77.71 | $248,672 | 129,463 | −2.41% | plan? |
| Mar 9, 2017 SForm 4 → | Mar 15, 8:40 pm EDT | Jacob Steven LeachSVP, Research & Development | 21,317 | $77.63 | $1,654,888 | 82,155 | −20.6% | plan? late |
| Mar 9, 2017 SForm 4 → | Mar 10, 8:49 pm EST | John ListerGeneral Manager, EMEA | 3,000 | $77.67 | $233,002 | 93,732 | −3.10% | plan? |
| Mar 8, 2017 ADForm 4 → | Mar 10, 8:50 pm EST | Richard DoubledayEVP, Chief Commercial Officer | 40,939 | $25.44 | $1,041,455 | 97,815 | — | plan? |
| Mar 8, 2017 AForm 4 → | Mar 10, 8:50 pm EST | Jeffrey MoySVP, Operations | 21,883 | $0.001 | $22 | 83,487 | — | plan? |
| Mar 8, 2017 ADForm 4 → | Mar 10, 8:49 pm EST | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 42,568 | $27.43 | $1,167,784 | 122,861 | — | plan? |
| Mar 8, 2017 ADMForm 4 → | Mar 10, 8:49 pm EST | John ListerGeneral Manager, EMEA | 35,832 | $21.73 | $778,659 | 84,034 | — | plan? |
| Mar 8, 2017 ADForm 4 → | Mar 10, 8:48 pm EST | Kevin R SayerPresident & CEO, Director | 118,271 | $24.26 | $2,868,756 | 343,680 | — | plan? |
| Mar 8, 2017 ADForm 4 → | Mar 10, 8:48 pm EST | Terrance H GreggExecutive Chairman, Director | 47,060 | $26.65 | $1,254,257 | 454,559 | — | plan? |
| Mar 8, 2017 AForm 4 → | Mar 10, 8:47 pm EST | Andrew K BaloEVP, Clinical and Regulatory | 28,761 | $0.001 | $29 | 132,663 | — | plan? |
| Mar 8, 2017 AForm 4 → | Mar 10, 8:46 pm EST | Donald AbbeyEVP Quality | 27,510 | $0.001 | $28 | 82,510 | — | plan? |
| Mar 8, 2017 ADForm 4 → | Mar 10, 8:45 pm EST | Patrick Michael MurphyVP, Legal Aff & Chf Compl Ofcr | 17,397 | $26.91 | $468,107 | 34,453 | — | plan? |
| Mar 6, 2017 SForm 4 → | Mar 8, 6:28 pm EST | Jay S SkylerDirector | 31,890 | $78.13 | $2,491,572 | 17,246 | −64.9% | plan? |
| Mar 6, 2017 MForm 4 → | Mar 8, 6:28 pm EST | Jay S SkylerDirector | 31,890 | $7.31 | $233,116 | 49,136 | — | plan? |
| Feb 23, 2017 SForm 4 → | Feb 24, 7:52 pm EST | Richard DoubledayEVP, Chief Commercial Officer | 3,182 | $78.42 | $249,530 | 12,733 | −20.0% | plan? |
| Feb 22, 2017 SForm 4 → | Feb 24, 7:51 pm EST | Jess RoperSVP, CFO | 2,333 | $78.76 | $183,759 | 10,452 | −18.2% | plan? |
| Feb 17, 2017 SForm 4 → | Feb 22, 6:14 pm EST | Kevin R SayerPresident & CEO, Director | 10,000 | $81.62 | $816,177 | 299,391 | −3.23% | plan? |
| Feb 17, 2017 MForm 4 → | Feb 22, 6:14 pm EST | Kevin R SayerPresident & CEO, Director | 10,000 | $8.79 | $87,900 | 309,391 | — | plan? |
| Feb 10, 2017 SForm 4 → | Feb 14, 7:49 pm EST | Andrew K BaloEVP, Clinical and Regulatory | 3,200 | $79.30 | $253,760 | 103,872 | −2.99% | plan? |
| Feb 10, 2017 MForm 4 → | Feb 14, 7:49 pm EST | Andrew K BaloEVP, Clinical and Regulatory | 727 | $9.80 | $7,125 | 107,072 | — | plan? |
| Feb 9, 2017 SForm 4 → | Feb 13, 7:19 pm EST | John ListerGeneral Manager, EMEA | 3,000 | $79.73 | $239,204 | 70,598 | −4.08% | plan? |
| Feb 9, 2017 MForm 4 → | Feb 13, 7:19 pm EST | John ListerGeneral Manager, EMEA | 3,000 | $8.85 | $26,550 | 73,598 | — | plan? |
| Feb 9, 2017 SForm 4 → | Feb 13, 7:18 pm EST | Jorge A ValdesCTO | 7,000 | $79.76 | $558,316 | 72,334 | −8.82% | plan? |
| Feb 9, 2017 MForm 4 → | Feb 13, 7:18 pm EST | Jorge A ValdesCTO | 7,000 | $9.80 | $68,600 | 79,334 | — | plan? |
| Feb 9, 2017 DForm 4 → | Feb 13, 7:18 pm EST | Terrance H GreggExecutive Chairman, Director | 1,421 | $79.35 | $112,756 | 439,845 | — | plan? |
| Feb 1, 2017 SForm 4 → | Feb 3, 7:49 pm EST | Jorge A ValdesCTO | 13,900 | $80.00 | $1,112,000 | 72,334 | −16.1% | plan? |
| Feb 1, 2017 MForm 4 → | Feb 3, 7:49 pm EST | Jorge A ValdesCTO | 13,900 | $9.80 | $136,220 | 86,234 | — | plan? |
| Jan 23, 2017 SForm 4 → | Jan 25, 8:49 pm EST | Richard DoubledayEVP, Chief Commercial Officer | 3,182 | $79.50 | $252,978 | 15,915 | −16.7% | plan? |
| Jan 23, 2017 SForm 4 → | Jan 25, 8:49 pm EST | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 9,637 | $79.99 | $770,908 | 110,409 | −8.03% | plan? |
| Jan 23, 2017 MForm 4 → | Jan 25, 8:49 pm EST | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 9,637 | $7.79 | $75,072 | 120,046 | — | plan? |
| Jan 18, 2017 SForm 4 → | Jan 20, 6:37 pm EST | Jess RoperSVP, CFO | 3,012 | $85.01 | $256,051 | 12,785 | −19.1% | plan? |
| Jan 17, 2017 SForm 4 → | Jan 19, 8:33 pm EST | Kevin R SayerPresident & CEO, Director | 10,000 | $85.94 | $859,362 | 299,391 | −3.23% | plan? |
| Jan 17, 2017 MForm 4 → | Jan 19, 8:33 pm EST | Kevin R SayerPresident & CEO, Director | 10,000 | $8.79 | $87,900 | 309,391 | — | plan? |
| Jan 13, 2017 SForm 4 → | Jan 18, 7:38 pm EST | John ListerGeneral Manager, EMEA | 15,000 | $79.36 | $1,190,400 | 70,598 | −17.5% | plan? |
| Jan 13, 2017 MForm 4 → | Jan 18, 7:38 pm EST | John ListerGeneral Manager, EMEA | 15,000 | $8.85 | $132,750 | 85,598 | — | plan? |
| Jan 13, 2017 SForm 4 → | Jan 18, 7:37 pm EST | Jorge A ValdesCTO | 26,100 | $80.00 | $2,088,000 | 72,334 | −26.5% | plan? |
| Jan 13, 2017 MForm 4 → | Jan 18, 7:37 pm EST | Jorge A ValdesCTO | 26,100 | $8.97 | $234,080 | 79,507 | — | plan? |
| Jan 10, 2017 SForm 4 → | Jan 12, 7:21 pm EST | Andrew K BaloEVP, Clinical and Regulatory | 3,200 | $62.86 | $201,152 | 106,345 | −2.92% | plan? |
| Jan 10, 2017 MForm 4 → | Jan 12, 7:21 pm EST | Andrew K BaloEVP, Clinical and Regulatory | 3,200 | $9.80 | $31,360 | 109,545 | — | plan? |
| Jan 9, 2017 SForm 4 → | Jan 11, 7:33 pm EST | John ListerGeneral Manager, EMEA | 3,000 | $63.02 | $189,046 | 70,598 | −4.08% | plan? |
| Jan 9, 2017 MForm 4 → | Jan 11, 7:33 pm EST | John ListerGeneral Manager, EMEA | 3,000 | $8.85 | $26,550 | 73,598 | — | plan? |
| Jan 9, 2017 SForm 4 → | Jan 11, 7:31 pm EST | Jorge A ValdesCTO | 10,900 | $63.02 | $686,905 | 72,334 | −13.1% | plan? |
| Jan 9, 2017 MForm 4 → | Jan 11, 7:31 pm EST | Jorge A ValdesCTO | 10,900 | $7.37 | $80,291 | 74,917 | — | plan? |
| Jan 9, 2017 DForm 4 → | Jan 11, 7:31 pm EST | Terrance H GreggExecutive Chairman, Director | 1,511 | $63.50 | $95,949 | 441,266 | — | plan? |
| Dec 23, 2016 SForm 4 → | Dec 28, 8:12 pm EST | Richard DoubledayEVP, Chief Commercial Officer | 3,182 | $62.17 | $197,831 | 19,097 | −14.3% | plan? |
| Dec 15, 2016 GForm 4 → | Dec 19, 5:46 pm EST | Terrance H GreggExecutive Chairman, Director | 10,000 | — | — | 55,882 | — | plan? |
| Dec 14, 2016 SForm 4 → | Dec 16, 7:20 pm EST | Jess RoperSVP, CFO | 2,442 | $64.14 | $156,619 | 15,797 | −13.4% | plan? |
| Dec 14, 2016 GForm 4 → | Dec 16, 7:20 pm EST | Kevin R SayerPresident & CEO, Director | 500 | — | — | 299,391 | — | plan? |
| Dec 9, 2016 SForm 4 → | Dec 13, 4:21 pm EST | Jorge A ValdesCTO | 10,000 | $64.81 | $648,079 | 72,334 | −12.1% | plan? |
| Dec 9, 2016 MForm 4 → | Dec 13, 4:21 pm EST | Jorge A ValdesCTO | 10,000 | $7.60 | $76,043 | 76,259 | — | plan? |
| Dec 9, 2016 DForm 4 → | Dec 12, 7:58 pm EST | Terrance H GreggExecutive Chairman, Director | 2,167 | $64.46 | $139,685 | 442,777 | — | plan? |
| Nov 23, 2016 SForm 4 → | Nov 28, 7:29 pm EST | Richard DoubledayEVP, Chief Commercial Officer | 3,182 | $70.19 | $223,350 | 22,279 | −12.5% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| May 8, 2015 MForm 4 → | May 12, 8:39 pm EDT | John ListerSr. VP, General Counsel | 2,396 | $68.49 | $164,091 | 0 | — | |
| May 7, 2015 MForm 4 → | May 11, 8:08 pm EDT | Terrance H GreggExecutive Chairman, Director | 91,483 | $67.85 | $6,206,811 | 0 | — | |
| May 4, 2015 MForm 4 → | May 5, 8:56 pm EDT | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $67.99 | $509,903 | 20,573 | — | |
| May 4, 2015 MForm 4 → | May 4, 7:58 pm EDT | Terrance H GreggExecutive Chairman, Director | 20,000 | $68.06 | $1,361,276 | 20,000 | — | |
| Apr 27, 2015 MForm 4 → | Apr 29, 8:39 pm EDT | Jeffrey MoySVP, Operations | 5,000 | $69.27 | $346,368 | 0 | — | |
| Apr 23, 2015 MForm 4 → | Apr 27, 5:50 pm EDT | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $69.65 | $522,353 | 28,073 | — | |
| Apr 21, 2015 MForm 4 → | Apr 23, 8:09 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 39,709 | $69.63 | $2,765,008 | 14,000 | — | |
| Apr 20, 2015 MForm 4 → | Apr 22, 7:32 pm EDT | Jess RoperSVP, CFO | 6,000 | $68.06 | $408,340 | 2,827 | — | |
| Apr 10, 2015 MForm 4 → | Apr 14, 6:54 pm EDT | Jeffrey MoySVP, Operations | 15,766 | $66.41 | $1,046,977 | 0 | — | |
| Apr 9, 2015 MForm 4 → | Apr 10, 7:45 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 20,000 | $65.03 | $1,300,511 | 39,709 | — | |
| Apr 9, 2015 MForm 4 → | Apr 10, 7:44 pm EDT | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $64.55 | $484,149 | 35,573 | — | |
| Apr 8, 2015 MForm 4 → | Apr 10, 7:44 pm EDT | Jorge A ValdesCTO | 8,244 | $63.81 | $526,048 | 16,487 | — | |
| Apr 8, 2015 MForm 4 → | Apr 10, 7:41 pm EDT | John ListerSr. VP, General Counsel | 5,039 | $63.84 | $321,680 | 2,396 | — | |
| Mar 25, 2015 MForm 4 → | Mar 27, 4:44 pm EDT | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $61.05 | $457,849 | 43,073 | — | |
| Mar 23, 2015 MForm 4 → | Mar 25, 6:15 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 4,000 | $61.25 | $244,992 | 2,000 | — | |
| Mar 23, 2015 MForm 4 → | Mar 25, 6:07 pm EDT | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 14,000 | $61.33 | $858,680 | 46,508 | — | |
| Mar 18, 2015 MForm 4 → | Mar 20, 5:08 pm EDT | Jess RoperSVP, CFO | 6,000 | $62.44 | $374,657 | 8,827 | — | |
| Mar 12, 2015 MForm 4 → | Mar 13, 8:04 pm EDT | Richard DoubledayEVP, Chief Commercial Officer | 20,000 | $59.23 | $1,184,677 | 988 | — | |
| Mar 11, 2015 MForm 4 → | Mar 13, 8:21 pm EDT | Jay S SkylerDirector | 45,000 | $60.01 | $2,700,297 | 0 | — | |
| Mar 11, 2015 MForm 4 → | Mar 13, 8:13 pm EDT | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $58.58 | $439,367 | 50,573 | — | |
| Mar 9, 2015 MForm 4 → | Mar 11, 7:43 pm EDT | Jorge A ValdesCTO | 8,244 | $58.77 | $484,529 | 24,731 | — | |
| Mar 9, 2015 MForm 4 → | Mar 10, 8:55 pm EDT | John ListerSr. VP, General Counsel | 5,039 | $58.77 | $296,156 | 7,435 | — | |
| Mar 2, 2015 MForm 4 → | Mar 4, 6:39 pm EST | Jeffrey MoySVP, Operations | 5,000 | $60.33 | $301,650 | 1,956 | — | |
| Feb 24, 2015 MForm 4 → | Feb 26, 8:44 pm EST | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $62.22 | $466,637 | 58,073 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 6:21 pm EST | Richard DoubledayEVP, Chief Commercial Officer | 4,000 | $63.58 | $254,334 | 6,000 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 6:18 pm EST | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 14,000 | $63.43 | $888,023 | 60,508 | — | |
| Feb 18, 2015 MForm 4 → | Feb 20, 6:00 pm EST | Jess RoperSVP, CFO | 6,000 | $61.89 | $371,341 | 14,827 | — | |
| Feb 17, 2015 MForm 4 → | Feb 19, 5:35 pm EST | Jeffrey MoySVP, Operations | 5,044 | $62.11 | $313,291 | 0 | — | |
| Feb 10, 2015 MForm 4 → | Feb 12, 7:22 pm EST | Andrew K BaloEVP, Clinical, Regulatory | 7,500 | $61.41 | $460,607 | 65,573 | — | |
| Feb 9, 2015 MForm 4 → | Feb 11, 8:06 pm EST | John ListerSr. VP, General Counsel | 5,039 | $61.66 | $310,693 | 12,474 | — | |
| Feb 9, 2015 MForm 4 → | Feb 11, 7:59 pm EST | Jorge A ValdesCTO | 8,244 | $61.67 | $508,380 | 32,975 | — | |
| Feb 2, 2015 MForm 4 → | Feb 4, 9:18 pm EST | Jeffrey MoySVP, Operations | 5,000 | $60.69 | $303,425 | 5,044 | — | |
| Jan 26, 2015 MForm 4 → | Jan 28, 9:10 pm EST | Andrew K BaloEVP, Clinical, Regulatory & | 15,001 | $59.25 | $888,739 | 0 | — | |
| Jan 23, 2015 MForm 4 → | Jan 27, 7:41 pm EST | Richard DoubledayEVP, Chief Commercial Officer | 4,000 | $58.22 | $232,864 | 10,000 | — | |
| Jan 23, 2015 MForm 4 → | Jan 27, 7:33 pm EST | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 24,532 | $59.67 | $1,463,812 | 9,996 | — | |
| Jan 20, 2015 MForm 4 → | Jan 22, 9:03 pm EST | Jess RoperSVP, CFO | 6,000 | $57.34 | $344,036 | 20,827 | — | |
| Jan 20, 2015 MForm 4 → | Jan 22, 8:54 pm EST | Jeffrey MoySVP, Operations | 5,000 | $57.58 | $287,906 | 10,044 | — | |
| Jan 12, 2015 MForm 4 → | Jan 14, 6:36 pm EST | Steven Robert PacelliEVP, Strategy & Corp. Dev. | 29,468 | $60.16 | $1,772,679 | 20,528 | — | |
| Jan 8, 2015 MForm 4 → | Jan 12, 8:49 pm EST | Jorge A ValdesCTO | 8,244 | $57.44 | $473,494 | 41,219 | — | |
| Jan 8, 2015 MForm 4 → | Jan 12, 8:36 pm EST | John ListerSr. VP, General Counsel | 5,039 | $57.42 | $289,337 | 2,452 | — | |
| Jan 5, 2015 MForm 4 → | Jan 7, 5:50 pm EST | Jeffrey MoySVP, Operations | 5,000 | $55.27 | $276,368 | 15,044 | — |